US Patent 10028954 Biheteroaryl compounds and uses thereof
Patent 10028954 was granted and assigned to Genentech on July, 2018 by the United States Patent and Trademark Office.
All edits
Edits on 11 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 8 Dec, 2023
Golden AI
Edits made to:
Article (+261 characters)
Article
Patent abstract
The present invention provides for compounds of Formula I and embodiments and salts thereof for the treatment of diseases (e.g., neurodegenerative diseases). R1, R2, R3, X1, X2, A and Cy variable in Formula all have the meaning as defined herein.
Edits on 1 Oct, 2023
Golden AI
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
Alan G Olivero0
Anthony Estrada0
Joseph Lyssikatos0
Michael Siu0
Snahel Patel0
Edits on 4 Apr, 2023
Golden AI
Infobox
Patent Citations Received
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
100289540
Date of Patent
July 24, 2018
0Patent Application Number
150413750
Date Filed
February 11, 2016
0Patent Citations Received
Patent Primary Examiner
Edits on 25 Sep, 2022
Golden AI
Infobox
Patent Citations Received
Edits on 1 Feb, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
Edits on 21 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10028954 Biheteroaryl compounds and uses thereof
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10028954
Date of patent
July 24, 2018
Patent application number
15041375
Date Filed
February 11, 2016
Patent primary examiner
Find more entities like US Patent 10028954 Biheteroaryl compounds and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
